FDA Collates GMP Data Integrity Advice Into New Guidance
This article was originally published in The Gold Sheet
Executive Summary
New Q&A-format draft guidance could help stave off the missteps flagged in recent warning letters, more of which focus on data integrity. One basic piece of advice: if data is generated to satisfy a CGMP requirement, then it is a CGMP record that must be retained.
You may also be interested in...
How To Find And Remedy Data Integrity Lapses In Microbiology Labs
Analytical chemistry labs may get all the attention when it comes to the search for data integrity failures, but FDA and industry experts say not to overlook the possibility of such failures in microbiology labs. Just keep in mind that the highly manual operations in these labs calls for a different approach to auditing.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.
US FDA, USP Raise Questions About Valisure’s Assertions Of Benzoyl Peroxide’s Benzene Risks
The US drug regulatory authority and standard-setting organization are evaluating the drug-screening venture’s findings regarding stability and potential carcinogenic risks associated with the widely used acne treatment, which includes Rx formulations.